Peregrine Pharma (NASDAQ: PPHM) announced that the company has entered into a sponsored research agreement with Memorial Sloan Kettering Cancer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE